Edwin M. Jacobs

1.1k total citations
21 papers, 801 citations indexed

About

Edwin M. Jacobs is a scholar working on Surgery, Molecular Biology and Genetics. According to data from OpenAlex, Edwin M. Jacobs has authored 21 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 6 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Edwin M. Jacobs's work include Testicular diseases and treatments (8 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Cancer Treatment and Pharmacology (4 papers). Edwin M. Jacobs is often cited by papers focused on Testicular diseases and treatments (8 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Cancer Treatment and Pharmacology (4 papers). Edwin M. Jacobs collaborates with scholars based in United States, Canada and Germany. Edwin M. Jacobs's co-authors include David A. Wood, Franco M. Muggia, James K. Luce, Joseph R. Bateman, Joseph T. Spaulding, David F. Paulson, John P. Donohue, Donald M. Stablein, Lawrence H. Einhorn and R B Weiss and has published in prestigious journals such as New England Journal of Medicine, JAMA and Cancer.

In The Last Decade

Edwin M. Jacobs

20 papers receiving 685 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edwin M. Jacobs United States	13	396	229	228	161	142	21	801
C. P. J. Vendrik Netherlands	12	358 0.9×	234 1.0×	342 1.5×	213 1.3×	104 0.7×	26	758
Robert Golbey United States	17	347 0.9×	163 0.7×	168 0.7×	179 1.1×	75 0.5×	27	666
J Chauvergne France	16	219 0.6×	208 0.9×	353 1.5×	121 0.8×	38 0.3×	107	833
V.J. Harvey New Zealand	11	127 0.3×	176 0.8×	319 1.4×	226 1.4×	80 0.6×	24	678
P H de Mulder Netherlands	13	272 0.7×	145 0.6×	322 1.4×	201 1.2×	86 0.6×	18	754
T. M. Scheinin Finland	15	222 0.6×	182 0.8×	261 1.1×	106 0.7×	25 0.2×	45	735
Lucien E. Nochomovitz United States	18	445 1.1×	247 1.1×	121 0.5×	133 0.8×	77 0.5×	38	800
K H Antman United States	15	178 0.4×	651 2.8×	485 2.1×	120 0.7×	71 0.5×	23	994
B. van der Werf‐Messing Netherlands	18	555 1.4×	463 2.0×	237 1.0×	102 0.6×	76 0.5×	34	1000
Greco Fa United States	11	171 0.4×	150 0.7×	277 1.2×	84 0.5×	81 0.6×	29	533

Countries citing papers authored by Edwin M. Jacobs

Since Specialization

Citations

This map shows the geographic impact of Edwin M. Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin M. Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin M. Jacobs more than expected).

Fields of papers citing papers by Edwin M. Jacobs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edwin M. Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin M. Jacobs. The network helps show where Edwin M. Jacobs may publish in the future.

Co-authorship network of co-authors of Edwin M. Jacobs

This figure shows the co-authorship network connecting the top 25 collaborators of Edwin M. Jacobs. A scholar is included among the top collaborators of Edwin M. Jacobs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edwin M. Jacobs. Edwin M. Jacobs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Williams, Stephen D., Donald M. Stablein, Lawrence H. Einhorn, et al.. (1988). Immediate Adjuvant Chemotherapy Versus Observation With Treatment at Relapse in Pathological Stage II Testicular Cancer. The Journal of Urology. 139(6). 1380–1380. 12 indexed citations

Williams, Stephen D., Donald M. Stablein, Lawrence H. Einhorn, et al.. (1987). Immediate Adjuvant Chemotherapy versus Observation with Treatment at Relapse in Pathological Stage II Testicular Cancer. New England Journal of Medicine. 317(23). 1433–1438. 256 indexed citations

Chlebowski, R. T., et al.. (1980). Adriamycin given as a weekly schedule without a loading course: clinically effective with reduced incidence of cardiotoxicity.. PubMed. 64(1). 47–51. 94 indexed citations

Jacobs, Edwin M. & Franco M. Muggia. (1980). Testicular Cancer: Risk Factors and the Role of Adjuvant Chemotherapy. Cancer. 45(S7). 1782–1790. 17 indexed citations

Jacobs, Edwin M., et al.. (1979). The National Cancer Institute Cooperative Clinical Trials Program. CA A Cancer Journal for Clinicians. 29(5). 287–290. 1 indexed citations

Jacobs, Edwin M., et al.. (1976). Effect of Trimethylcolchicinic Acid Methyl Ether d-Tartrate (TMCA) on Hodgkin’s and Non-Hodgkin’s Lymphoma. Oncology. 33(4). 151–153. 5 indexed citations

Kardinal, Carl G., et al.. (1976). Evaluation of bleomycin, adriamycin, and vinblastine in combination therapy for advanced testicular tumors.. PubMed. 60(7). 953–4. 1 indexed citations

Pugh, Reginald P., et al.. (1976). Bleomycin (NSC-125066) Therapy of Responsive Solid Tumors. Oncology. 33(5-6). 260–264. 5 indexed citations

Wharam, Moody D., Theodore L. Phillips, & Edwin M. Jacobs. (1974). Combination chemotherapy and whole lung irradiation for pulmonary metastases from sarcomas and germinal cell tumors of the testis. Cancer. 34(1). 136–142. 9 indexed citations

10.

Jacobs, Edwin M., et al.. (1971). Treatment of cancer with weekly intravenous 5-fluorouracil.Study by the Western Cooperative Cancer Chemotherapy Group (WCCCG). Cancer. 27(6). 1302–1305. 46 indexed citations

11.

Jacobs, Edwin M., et al.. (1971). Chemotherapy of metastatic malignant melanoma.Experience with 73 patients. Cancer. 27(6). 1306–1312. 19 indexed citations

12.

Silverberg, Ivan & Edwin M. Jacobs. (1971). Treatment of spinal cord compression in Hodgkin's disease. Cancer. 27(2). 308–313. 19 indexed citations

13.

Jacobs, Edwin M.. (1970). Combination chemotherapy of metastatic testicular germinal cell tumors and soft part sarcomas. Cancer. 25(2). 324–332. 63 indexed citations

14.

Solomon, Joel, Reginald P. Pugh, Edwin M. Jacobs, et al.. (1970). clinical experience with procarbazine in Hodgkin's disease, reticulum cell sarcoma, and lymphosarcoma. Cancer. 26(5). 984–990. 27 indexed citations

15.

Jacobs, Edwin M.. (1968). Mechlorethamine HCl and Cyclophosphamide in the Treatment of Hodgkin's Disease and the Lymphomas. JAMA. 203(6). 392–392. 38 indexed citations

16.

Jacobs, Edwin M., James K. Luce, & David A. Wood. (1968). Treatment of cancer with weekly intravenous 5-fluorouracil. Cancer. 22(6). 1233–1238. 56 indexed citations

17.

Jacobs, Edwin M.. (1967). Benign thymoma and selective erythroid aplasia of the bone marrow.. PubMed. 107(6). 508–9. 1 indexed citations

18.

Jacobs, Edwin M., James K. Luce, & Relda Cailleau. (1966). Chromosome abnormalities in human cancer. Report of a patient with chronic myelocytic leukemia and his nonleukemic monozygotic twin. Cancer. 19(6). 869–876. 26 indexed citations

19.

Jacobs, Edwin M., et al.. (1966). Hodgkin's disease terminating in chronic myeloid leukemia.. PubMed. 104(6). 479–84. 12 indexed citations

20.

Jacobs, Edwin M., R. V. P. Hutter, John L. Pool, & Allyn B. Ley. (1959). Benign thymoma and selective erythroid aplasia of the bone marrow. Cancer. 12(1). 47–57. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact